Rapid Dose Therapeutics Corp. News Releases

Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip(TM) Nicotine Patent, Advancing RDT's Global Commercialization Strategy

Thu, 20 Aug 2026 08:30:00 -0400

Second granted nicotine oral-film patent strengthens RDT's intellectual-property portfolio and its collaboration with a global nicotine industry leader, advancing the Company's strategy to build a protected global nicotine delivery platform. Burlington, Ontario--(Newsfile Corp. - August 20, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company specializing in innovative oral thin film drug delivery technology, today announced...

Rapid Dose Therapeutics (DOSE) (RDTCF) and Bodhi Health Expand Distribution and Sales of CurcuWIN(R) QuickStrip(TM) Curcumin Across Canada

Tue, 28 Jul 2026 16:05:00 -0400

Burlington, Ontario--(Newsfile Corp. - July 28, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("Rapid Dose" or "RDT"), a Canadian biotechnology company, and Ontario-based Bodhi Health Inc. ("Bodhi Health") today announced an expansion of their coordinated distribution, sales and market-development efforts for Bodhi Health Sublingual Curcumin, manufactured using Rapid Dose's proprietary QuickStrip™ oral thin-film technology and the patented CurcuWIN® curcumin formulation, with...

Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Fri, 10 Jul 2026 19:13:00 -0400

Burlington, Ontario--(Newsfile Corp. - July 10, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated secured convertible notes dated December 1, 2025 (the "Notes"), the Company issued common shares ("Common Shares") in satisfaction of the accrued interest payable on June 30, 2026. The Notes were issued as a result of an extension to the promissory notes that were originally issued by the Company...

Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization

Tue, 07 Jul 2026 07:00:00 -0400

Burlington, Ontario--(Newsfile Corp. - July 7, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company specializing in oral thin film drug delivery technology, is pleased to announce the execution of a Memorandum of Understanding ("MOU") with a global leader in the nicotine products industry, extending the parties' ongoing collaboration surrounding RDT's proprietary QuickStrip™ dissolvable oral nicotine strip technology.The MOU,...

Rapid Dose Therapeutics (DOSE) (RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets

Mon, 13 Apr 2026 09:51:00 -0400

Burlington, Ontario--(Newsfile Corp. - April 13, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company developing oral thin film drug delivery technologies, today announced the initiation of clean room upgrades and facility retrofitting at its Burlington, Ontario manufacturing site, positioning the Company for pharmaceutical expansion, regulatory advancement, and global commercialization opportunities.The upgrade program is...

Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Mon, 06 Apr 2026 16:30:00 -0400

Burlington, Ontario--(Newsfile Corp. - April 6, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated secured convertible notes dated December 1, 2025 (the "Notes"), the Company intends to issue common shares ("Common Shares") in satisfaction of the accrued interest payable on March 31, 2026. The Company expects to issue the Common Shares no later than April 15, 2026.The Notes were issued...

Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory

Thu, 26 Mar 2026 09:09:00 -0400

Burlington, Ontario--(Newsfile Corp. - March 26, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology leader specializing in innovative oral thin film drug delivery, is pleased to provide shareholders with a strategic update highlighting its continued execution, operational resilience, and expanding global footprint.In an environment marked by global market volatility and geopolitical uncertainty, RDT is uniquely positioned with a...

Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market

Thu, 05 Mar 2026 10:08:00 -0500

Burlington, Ontario--(Newsfile Corp. - March 5, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF), a Canadian biotechnology company specializing in oral thin film drug delivery technology, today announced the grant of a key patent for its QuickStrip™ Nicotine Bilayer Oral Film in partnership with Aavishkar Oral Strips.The patent, titled "Nicotine Bilayer Oral Film and Process for Preparation Thereof," has been granted by the Indian Patent Office under Patent Number IN 582202,...

Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform

Mon, 23 Feb 2026 06:12:00 -0500

Burlington, Ontario--(Newsfile Corp. - February 23, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company focused on innovative drug delivery solutions, today provided an update on its ongoing cannabinoid research initiatives and clinical evaluation of its proprietary QuickStrip™ oral thin film delivery platform.Independent research led by colleagues Dr. Patrick Neary of the Faculty of Kinesiology & Health...

Rapid Dose Therapeutics Begins Trading on the OTCQB in the United States Under Symbol RDTCF, Expanding Access for U.S. Healthcare and Biotechnology Investors

Wed, 11 Feb 2026 11:21:00 -0500

Burlington, Ontario--(Newsfile Corp. - February 11, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company revolutionizing drug delivery through innovation, today announced that its common shares are now trading in the United States on the OTCQB Venture Market under the ticker symbol RDTCF.The OTCQB listing expands Rapid Dose Therapeutics' presence in the U.S. capital markets by increasing accessibility and visibility for...